# An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)

> **NCT01498770** · — · COMPLETED · sponsor: **Organon and Co** · enrollment: 42 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Asenapine
- **DRUG:** Aripiprazole
- **DRUG:** Quetiapine
- **DRUG:** Risperidone
- **DRUG:** Olanzapine
- **DRUG:** Ziprasidone
- **DRUG:** Iloperidone
- **DRUG:** Paliperidone
- **DRUG:** Lurasidone
- **DRUG:** Clozapine
- **DRUG:** Amisulpride
- **DRUG:** Sertindole
- **DRUG:** Zotepine

## Key facts

- **NCT ID:** NCT01498770
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04-01
- **Primary completion:** 2017-12-21
- **Final completion:** 2017-12-21
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01498770

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01498770, "An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01498770. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*